Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IQVIA HOLDINGS INC. | EVP & Chief Financial Officer | Common Stock | 31.4K | $6.85M | $218.20 | Feb 10, 2024 | Direct |
IQVIA HOLDINGS INC. | EVP & Chief Financial Officer | Common Stock | 11.9K | $2.6M | $218.20 | Feb 9, 2024 | By Trust |
IQVIA HOLDINGS INC. | EVP & Chief Financial Officer | Stock Appreciation Right | 20.7K | $1.24M | $59.90 | Feb 7, 2024 | Direct |
GoodRx Holdings, Inc. | Director | Class A Common Stock | 21.6K | $109K | $5.04 | Nov 8, 2024 | Direct |
GoodRx Holdings, Inc. | Director | Deferred Stock Unit | 65.1K | Nov 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GDRX | GoodRx Holdings, Inc. | Nov 8, 2024 | 0 | $0 | 3 | Nov 12, 2024 | Director |
GDRX | GoodRx Holdings, Inc. | Nov 8, 2024 | 3 | $0 | 4 | Nov 12, 2024 | Director |
IQV | IQVIA HOLDINGS INC. | Feb 9, 2024 | 2 | -$423K | 4 | Feb 13, 2024 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Feb 6, 2024 | 3 | -$2.26M | 4 | Feb 8, 2024 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Aug 3, 2023 | 1 | -$560K | 4 | Aug 7, 2023 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Feb 13, 2023 | 1 | $0 | 4 | Feb 15, 2023 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Feb 9, 2023 | 2 | -$302K | 4 | Feb 13, 2023 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Aug 3, 2022 | 1 | -$604K | 4 | Aug 5, 2022 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Feb 9, 2022 | 1 | -$180K | 4 | Feb 11, 2022 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Sep 23, 2021 | 2 | $23.60 | 4 | Feb 17, 2022 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Aug 3, 2021 | 1 | $0 | 4 | Aug 5, 2021 | EVP & Chief Financial Officer |
IQV | IQVIA HOLDINGS INC. | Jul 20, 2021 | 3 | $3.19K | 4 | Feb 14, 2022 | EVP & Chief Financial Officer |